Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonectomy | 4 | 2023 | 211 | 1.480 |
Why?
|
| Education, Medical, Graduate | 2 | 2020 | 403 | 1.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 1131 | 0.780 |
Why?
|
| Neoplasm Metastasis | 4 | 2020 | 1066 | 0.770 |
Why?
|
| Lung Neoplasms | 4 | 2023 | 2370 | 0.760 |
Why?
|
| General Surgery | 2 | 2020 | 236 | 0.730 |
Why?
|
| Acetophenones | 1 | 2020 | 27 | 0.720 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2020 | 30 | 0.710 |
Why?
|
| Actomyosin | 1 | 2020 | 46 | 0.690 |
Why?
|
| Surgeons | 2 | 2023 | 249 | 0.690 |
Why?
|
| Surgery Department, Hospital | 1 | 2020 | 44 | 0.690 |
Why?
|
| Cytoskeleton | 1 | 2020 | 195 | 0.640 |
Why?
|
| Simulation Training | 1 | 2020 | 100 | 0.630 |
Why?
|
| Consensus | 1 | 2020 | 366 | 0.620 |
Why?
|
| Computer Simulation | 1 | 2020 | 1102 | 0.520 |
Why?
|
| Informed Consent | 1 | 2018 | 275 | 0.500 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.490 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 305 | 0.490 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2014 | 9 | 0.460 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2014 | 10 | 0.460 |
Why?
|
| Internship and Residency | 2 | 2020 | 1063 | 0.450 |
Why?
|
| Choristoma | 1 | 2014 | 68 | 0.450 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2024 | 56 | 0.440 |
Why?
|
| Pancreas | 1 | 2014 | 253 | 0.400 |
Why?
|
| Carotid Artery, Internal | 1 | 2012 | 69 | 0.400 |
Why?
|
| Endarterectomy, Carotid | 1 | 2012 | 74 | 0.390 |
Why?
|
| Carotid Stenosis | 1 | 2012 | 117 | 0.380 |
Why?
|
| Colorectal Neoplasms | 4 | 2020 | 980 | 0.350 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2018 | 120 | 0.260 |
Why?
|
| Humans | 22 | 2025 | 90014 | 0.250 |
Why?
|
| Neoplasm Staging | 2 | 2023 | 2000 | 0.250 |
Why?
|
| HCT116 Cells | 3 | 2020 | 156 | 0.250 |
Why?
|
| Mesothelioma | 2 | 2025 | 323 | 0.220 |
Why?
|
| Esophageal Stenosis | 1 | 2023 | 26 | 0.210 |
Why?
|
| Pleural Neoplasms | 1 | 2025 | 200 | 0.210 |
Why?
|
| Frailty | 1 | 2024 | 79 | 0.210 |
Why?
|
| Thoracic Surgery | 1 | 2023 | 47 | 0.200 |
Why?
|
| Cell Adhesion | 2 | 2020 | 426 | 0.200 |
Why?
|
| Bronchial Fistula | 1 | 2021 | 9 | 0.190 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2021 | 10 | 0.190 |
Why?
|
| Pancreatic Neoplasms | 2 | 2018 | 684 | 0.190 |
Why?
|
| Esophageal Fistula | 1 | 2021 | 11 | 0.190 |
Why?
|
| Liver Neoplasms | 2 | 2019 | 755 | 0.190 |
Why?
|
| Immunotherapy | 2 | 2025 | 699 | 0.180 |
Why?
|
| Esophageal Neoplasms | 1 | 2023 | 332 | 0.180 |
Why?
|
| Organizational Innovation | 1 | 2020 | 43 | 0.180 |
Why?
|
| Education, Distance | 1 | 2020 | 25 | 0.170 |
Why?
|
| Computer-Assisted Instruction | 1 | 2020 | 44 | 0.170 |
Why?
|
| Workload | 1 | 2020 | 129 | 0.160 |
Why?
|
| Treatment Outcome | 5 | 2023 | 8292 | 0.160 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2020 | 96 | 0.160 |
Why?
|
| Infection Control | 1 | 2020 | 124 | 0.160 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 98 | 0.160 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 153 | 0.160 |
Why?
|
| Mice, Nude | 1 | 2020 | 816 | 0.150 |
Why?
|
| Polymers | 1 | 2019 | 196 | 0.150 |
Why?
|
| Clinical Competence | 2 | 2020 | 797 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2019 | 165 | 0.150 |
Why?
|
| Female | 8 | 2024 | 46618 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 262 | 0.140 |
Why?
|
| Actins | 1 | 2020 | 462 | 0.140 |
Why?
|
| Cell Movement | 1 | 2020 | 787 | 0.140 |
Why?
|
| Disease Management | 1 | 2019 | 327 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 281 | 0.140 |
Why?
|
| Pancreatectomy | 1 | 2017 | 164 | 0.130 |
Why?
|
| Peritoneal Neoplasms | 1 | 2017 | 181 | 0.130 |
Why?
|
| Chicago | 1 | 2020 | 1434 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1704 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2023 | 9237 | 0.120 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 848 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 778 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2019 | 556 | 0.110 |
Why?
|
| Aged | 7 | 2024 | 19272 | 0.110 |
Why?
|
| Endosonography | 1 | 2014 | 99 | 0.110 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2014 | 163 | 0.100 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2012 | 42 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 359 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 855 | 0.090 |
Why?
|
| Reoperation | 1 | 2012 | 605 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 983 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2395 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 2677 | 0.080 |
Why?
|
| Disease Progression | 1 | 2012 | 1469 | 0.070 |
Why?
|
| Time Factors | 2 | 2017 | 5361 | 0.070 |
Why?
|
| Male | 6 | 2024 | 42706 | 0.070 |
Why?
|
| Mice | 1 | 2020 | 11859 | 0.070 |
Why?
|
| Animals | 3 | 2020 | 27537 | 0.060 |
Why?
|
| Length of Stay | 2 | 2020 | 749 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2012 | 2327 | 0.060 |
Why?
|
| Frail Elderly | 1 | 2024 | 80 | 0.060 |
Why?
|
| Stroke | 1 | 2012 | 994 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2024 | 232 | 0.050 |
Why?
|
| Elective Surgical Procedures | 1 | 2024 | 129 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2023 | 84 | 0.050 |
Why?
|
| Esophagectomy | 1 | 2023 | 91 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 222 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2023 | 277 | 0.050 |
Why?
|
| Postoperative Complications | 2 | 2024 | 2316 | 0.050 |
Why?
|
| Risk Factors | 1 | 2012 | 5562 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 313 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2023 | 258 | 0.050 |
Why?
|
| Professional Autonomy | 1 | 2020 | 41 | 0.040 |
Why?
|
| Body Composition | 1 | 2020 | 71 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2021 | 162 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 490 | 0.040 |
Why?
|
| Sex Factors | 1 | 2023 | 1075 | 0.040 |
Why?
|
| Medicare | 1 | 2023 | 427 | 0.040 |
Why?
|
| Endosomes | 1 | 2019 | 79 | 0.040 |
Why?
|
| Adult | 2 | 2018 | 26836 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 137 | 0.040 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2018 | 36 | 0.040 |
Why?
|
| United States | 2 | 2023 | 7114 | 0.040 |
Why?
|
| Hospitals | 1 | 2020 | 303 | 0.040 |
Why?
|
| Genomics | 1 | 2023 | 778 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2770 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1731 | 0.040 |
Why?
|
| Margins of Excision | 1 | 2017 | 42 | 0.040 |
Why?
|
| beta Catenin | 1 | 2019 | 267 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 569 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2018 | 290 | 0.030 |
Why?
|
| Critical Care | 1 | 2020 | 384 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 1091 | 0.030 |
Why?
|
| Middle Aged | 3 | 2023 | 26173 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 397 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 2360 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2017 | 355 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 866 | 0.030 |
Why?
|
| Patient Selection | 1 | 2017 | 682 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 1899 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1670 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1604 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 603 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 1134 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2658 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2017 | 780 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6787 | 0.020 |
Why?
|